Johanna Strandell

677 total citations
15 papers, 489 citations indexed

About

Johanna Strandell is a scholar working on Toxicology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Johanna Strandell has authored 15 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Toxicology, 6 papers in Pharmacology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Johanna Strandell's work include Pharmacovigilance and Adverse Drug Reactions (8 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Computational Drug Discovery Methods (3 papers). Johanna Strandell is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (8 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Computational Drug Discovery Methods (3 papers). Johanna Strandell collaborates with scholars based in Sweden, United Kingdom and Denmark. Johanna Strandell's co-authors include Ebba Holme Hansen, Lise Aagaard, David W. J. Clark, Gunnar Carlin, A. Neil, I. Ralph Edwards, Andrew Bate, Staffan Hägg, G. Niklas Norén and Ola Caster and has published in prestigious journals such as British Journal of Clinical Pharmacology, Phytomedicine and Drug Safety.

In The Last Decade

Johanna Strandell

13 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johanna Strandell Sweden 9 249 99 96 80 66 15 489
Taofikat B. Agbabiaka United Kingdom 10 164 0.7× 79 0.8× 115 1.2× 124 1.6× 67 1.0× 12 666
Cecilia Biriell Sweden 7 189 0.8× 87 0.9× 44 0.5× 84 1.1× 57 0.9× 10 423
Syed Rizwanuddin Ahmad United States 6 164 0.7× 71 0.7× 228 2.4× 102 1.3× 70 1.1× 12 580
Stephen A. Goldman United States 7 109 0.4× 63 0.6× 33 0.3× 45 0.6× 40 0.6× 20 407
Lateef M. Khan Saudi Arabia 12 142 0.6× 91 0.9× 28 0.3× 43 0.5× 30 0.5× 27 431
Vaishali Patadia United States 9 347 1.4× 69 0.7× 53 0.6× 92 1.1× 95 1.4× 13 525
Sabine Krebs Germany 10 208 0.8× 206 2.1× 48 0.5× 82 1.0× 54 0.8× 22 472
Shannon Manzi United States 14 83 0.3× 117 1.2× 110 1.1× 59 0.7× 22 0.3× 29 671
Carl J Heneghan United Kingdom 6 88 0.4× 52 0.5× 116 1.2× 36 0.5× 57 0.9× 8 583
C. Noblet France 8 280 1.1× 149 1.5× 57 0.6× 148 1.9× 59 0.9× 17 633

Countries citing papers authored by Johanna Strandell

Since Specialization
Citations

This map shows the geographic impact of Johanna Strandell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johanna Strandell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johanna Strandell more than expected).

Fields of papers citing papers by Johanna Strandell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johanna Strandell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johanna Strandell. The network helps show where Johanna Strandell may publish in the future.

Co-authorship network of co-authors of Johanna Strandell

This figure shows the co-authorship network connecting the top 25 collaborators of Johanna Strandell. A scholar is included among the top collaborators of Johanna Strandell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johanna Strandell. Johanna Strandell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Strandell, Johanna, Ola Caster, Johan Hopstadius, I. Ralph Edwards, & G. Niklas Norén. (2013). The Development and Evaluation of Triage Algorithms for Early Discovery of Adverse Drug Interactions. Drug Safety. 36(5). 371–388. 24 indexed citations
2.
Star, Kristina, et al.. (2012). Temporal Pattern Discovery on Electronic Health Records - A Source of Reference in Signal Detection Work. Pharmacoepidemiology and Drug Safety. 21. 347–347. 1 indexed citations
3.
Aagaard, Lise, et al.. (2012). Global Patterns of Adverse Drug Reactions Over a Decade. Drug Safety. 35(12). 1171–1182. 105 indexed citations
4.
Strandell, Johanna, G. Niklas Norén, & Staffan Hägg. (2012). Key Elements in Adverse Drug Interaction Safety Signals. Drug Safety. 36(1). 63–70. 8 indexed citations
5.
Aagaard, Lise, et al.. (2012). Global Patterns of Adverse Drug Reactions Over a Decade. Drug Safety. 35(12). 1171–1182. 97 indexed citations
6.
Strandell, Johanna, Ola Caster, Andrew Bate, G. Niklas Norén, & I. Ralph Edwards. (2011). Reporting Patterns Indicative of Adverse Drug Interactions. Drug Safety. 34(3). 253–266. 28 indexed citations
7.
Strandell, Johanna, et al.. (2011). Pharmacodynamic and pharmacokinetic drug interactions reported to VigiBase, the WHO global individual case safety report database. European Journal of Clinical Pharmacology. 67(6). 633–641. 37 indexed citations
8.
Strandell, Johanna. (2011). Drug interaction surveillance using individual case safety reports. KTH Publication Database DiVA (KTH Royal Institute of Technology). 2 indexed citations
9.
Strandell, Johanna, Andrew Bate, Staffan Hägg, & I. Ralph Edwards. (2009). Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction. British Journal of Clinical Pharmacology. 68(3). 427–434. 41 indexed citations
10.
Strandell, Johanna & Kristina Star. (2007). Reports of Suicide Related Behaviour with Methylphenidate and Atomoxetine in Children and Adolescents. Drug Safety. 30(10). 919–990.
11.
Strandell, Johanna, et al.. (2006). Can WHO-Database of Suspected ADRs Be Used to Support Existing Information on Pharmacokinetic Drug Interactions?. Drug Safety. 29(10). 911–1010. 1 indexed citations
12.
Clark, David W. J. & Johanna Strandell. (2006). Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?. European Journal of Clinical Pharmacology. 62(6). 473–479. 64 indexed citations
13.
Strandell, Johanna, et al.. (2006). Concomitant Use of Glucosamine Potentiates the Effect of Warfarin. Drug Safety. 29(10). 911–1010. 9 indexed citations
14.
Strandell, Johanna, A. Neil, & Gunnar Carlin. (2004). An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies. Phytomedicine. 11(2-3). 98–104. 72 indexed citations
15.
Conforti, Anita, et al.. (2004). Ciclosporin and serious intestinal disorders. 27(12). 924–924.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026